Literature DB >> 6349965

Acute secretory diarrheas. Current concepts in pathogenesis and treatment.

S Hughes.   

Abstract

Acute secretory diarrheas constitute a major source of mortality and morbidity world-wide. Our current understanding of the underlying mechanisms involved is reviewed with particular reference to cholera and enterotoxigenic E. coli infections. From the physiological principles involved, a unified concept for the treatment of acute secretory diarrheas is presented. The importance of rehydration is highlighted and practical instructions for the use of oral glucose-electrolyte solutions in the treatment of acute secretory diarrhoeas are given, along with some discussion of the rationale behind their use and optimum composition. The important role of nutritional factors during acute diarrhoea is underlined and the place of various drugs, some established, some experimental, are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349965     DOI: 10.2165/00003495-198326010-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  18 in total

1.  TETRACYCLINE IN THE TREATMENT OF CHOLERA.

Authors:  W B GREENOUGH; R S GORDON; I S ROSENBERG; B I DAVIES; A S BENENSON
Journal:  Lancet       Date:  1964-02-15       Impact factor: 79.321

2.  Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university.

Authors:  H L DuPont; P Sullivan; L K Pickering; G Haynes; P B Ackerman
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

3.  Comparison of sucrose and glucose in the oral electrolyte therapy of cholera and other severe diarrheas.

Authors:  D L Palmer; F T Koster; A F Islam; A S Rahman; R B Sack
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

4.  Single solution for oral therapy of diarrhoea.

Authors:  K J Bart; L Finberg
Journal:  Lancet       Date:  1976-09-18       Impact factor: 79.321

5.  Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone.

Authors:  H L DuPont; E Galindo; D G Evans; F J Cabada; P Sullivan; D J Evans
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

6.  The use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases.

Authors:  M R Islam; D A Sack; J Holmgren; P K Bardhan; G H Rabbani
Journal:  Gastroenterology       Date:  1982-06       Impact factor: 22.682

7.  Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth).

Authors:  H L DuPont; P Sullivan; D G Evans; L K Pickering; D J Evans; J J Vollet; C D Ericsson; P B Ackerman; W S Tjoa
Journal:  JAMA       Date:  1980-01-18       Impact factor: 56.272

Review 8.  The treatment of acute diarrhea in children. An historical and physiological perspective.

Authors:  N Hirschhorn
Journal:  Am J Clin Nutr       Date:  1980-03       Impact factor: 7.045

9.  Chlorpromazine reduces fluid-loss in cholera.

Authors:  G H Rabbani; W B Greenough; J Holmgren; I Lönnroth
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

10.  Brief prophylaxis with doxycycline for the prevention of traveler's diarrhea.

Authors:  L D Freeman; D R Hooper; D F Lathen; D P Nelson; W O Harrison; D S Anderson
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

View more
  1 in total

Review 1.  Adverse effects of drugs used in the management of constipation and diarrhoea.

Authors:  J M Gattuso; M A Kamm
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.